[Pathological Diagnostic Testing and Biomarkers for Perioperative System Therapy]

Area of Science:

• Oncology
• Pathology
• Molecular Diagnostics

Background:

• Personalized treatment for resectable lung cancer hinges on high-quality pathological analysis of tissue samples.
• Accurate histological typing, staging, grading, and assessment of resection status are essential diagnostic components.
• Biomarker determination (e.g., EGFR, ALK, PD-L1) is critical for guiding treatment decisions in early-stage non-small cell lung cancer (NSCLC).

Purpose of the Study:

• To emphasize the necessity of quality-assured, standardized, and prompt pathological processing for optimal lung cancer treatment planning.
• To highlight the role of histopathological typing, grading, and molecular biomarker analysis in personalized oncology.
• To underscore the importance of adhering to international standards for testing predictive and prognostic markers.

Main Methods:

• Histopathological examination of Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples.
• Tumor typing according to the current World Health Organization (WHO) classification.
• Assessment of staging, tumor grading, resection status (R classification), and regression grading.
• Molecular biomarker testing for EGFR, ALK, and PD-L1.

Main Results:

• Accurate histopathological typing (adenocarcinomas, squamous cell carcinomas, NSCLCs, neuroendocrine carcinomas) is fundamental.
• Standardized tumor grading, particularly for invasive non-mucinous adenocarcinoma, provides prognostic risk assessment.
• R classification and regression grading offer additional prognostic relevance.
• Molecular biomarker analysis (EGFR, ALK, PD-L1) informs individualized treatment strategies for early-stage NSCLC.

Conclusions:

• Quality-assured and standardized pathological processing of lung cancer tissue is indispensable for effective personalized treatment.
• Comprehensive histopathological evaluation combined with molecular biomarker testing ensures optimal patient management.
• Adherence to international standards in diagnostic testing is paramount for reliable predictive and prognostic information.